Literature DB >> 9201226

The influenza A virus M2 channel: a molecular modeling and simulation study.

M S Sansom1, I D Kerr, G R Smith, H S Son.   

Abstract

The M2 protein of influenza virus forms ion channels activated by low pH which are proton permeable and play a key role in the life cycle of the virus. M2 is a 97-residue integral membrane protein containing a single transmembrane (TM) helix. M2 is present as disulfide-linked homotetramers. The TM domain of M2 has been modeled as a bundle of four parallel M2 helices. The helix bundle forms a left-handed supercoil surrounding a central pore. Residue H37 has been implicated in the mechanism of low-pH activation of the channel. Models generated with H37 in a fully deprotonated state exhibit a pore occluded by a ring of H37 side chains oriented toward the lumen of the pore. Models with H37 in a fully protonated state no longer exhibit such occlusion of the pore, as the H37 side chains adopt a more interfacial location. Extended molecular dynamics simulations with water molecules within and at the mouths of the pores support this distinction between the H37-deprotonated and H37-protonated models. These simulations suggest that only in the H37-protonated model is there a continuous column of water extending the entire length of the central pore. A mechanism for activation of M2 by low pH is presented in which the H37-deprotonated model corresponds to the "closed" form of the channel, while the H37-protonated model corresponds to the "open" form. A switch from the closed to the open form of the channel occurs if H37 is protonated midway through a simulation. The open channel is suggested to contain a wire of H-bonded water molecules which enables proton permeability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201226     DOI: 10.1006/viro.1997.8578

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  65 in total

1.  An alamethicin channel in a lipid bilayer: molecular dynamics simulations.

Authors:  D P Tieleman; H J Berendsen; M S Sansom
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

2.  pH-dependent tetramerization and amantadine binding of the transmembrane helix of M2 from the influenza A virus.

Authors:  D Salom; B R Hill; J D Lear; W F DeGrado
Journal:  Biochemistry       Date:  2000-11-21       Impact factor: 3.162

3.  A Grand Canonical Monte Carlo-Brownian dynamics algorithm for simulating ion channels.

Authors:  W Im; S Seefeld; B Roux
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

4.  Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation.

Authors:  A Deora; L Ratner
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Calculation of rigid-body conformational changes using restraint-driven Cartesian transformations.

Authors:  P Sompornpisut; Y S Liu; E Perozo
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

6.  Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus.

Authors:  K Tobler; M L Kelly; L H Pinto; R A Lamb
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Analysis of the pore structure of the influenza A virus M(2) ion channel by the substituted-cysteine accessibility method.

Authors:  K Shuck; R A Lamb; L H Pinto
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Membrane peptides and their role in protobiological evolution.

Authors:  Andrew Pohorille; Michael A Wilson; Christophe Chipot
Journal:  Orig Life Evol Biosph       Date:  2003-04       Impact factor: 1.950

9.  Molecular dynamics simulation of proton transport through the influenza A virus M2 channel.

Authors:  Alexander M Smondyrev; Gregory A Voth
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

Review 10.  Ion channels as antivirus targets.

Authors:  Xin Liang; Zhi-Yuan Li
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.